Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy

Claudia M. Campbell, Mark S. Kipnes, Bruce C. Stouch, Kerrie L. Brady, Margaret Kelly, William K. Schmidt, Karin L. Petersen, Michael C. Rowbotham, James N. Campbell

Research output: Contribution to journalArticlepeer-review

Abstract

A length-dependent neuropathy with pain in the feet is a common complication of diabetes (painful diabetic neuropathy). It was hypothesized that pain may arise from sensitized-hyperactive cutaneous nociceptors, and that this abnormal signaling may be reduced by topical administration of the α2-adrenergic agonist, clonidine, to the painful area. This was a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial. Nociceptor function was measured by determining the painfulness of 0.1% topical capsaicin applied to the pretibial area of each subject for 30 minutes during screening. Subjects were then randomized to receive 0.1% topical clonidine gel (n = 89) or placebo gel (n = 90) applied 3 times a day to their feet for 12 weeks. The difference in foot pain at week 12 in relation to baseline, rated on a 0-10 numerical pain rating scale (NPRS), was compared between groups. Baseline NPRS was imputed for missing data for subjects who terminated the study early. The subjects treated with clonidine showed a trend toward decreased foot pain compared to the placebo-treated group (the primary endpoint; P = 0.07). In subjects who felt any level of pain to capsaicin, clonidine was superior to placebo (P < 0.05). In subjects with a capsaicin pain rating ≥2 (0-10, NPRS), the mean decrease in foot pain was 2.6 for active compared to 1.4 for placebo (P = 0.01). Topical clonidine gel significantly reduces the level of foot pain in painful diabetic neuropathy subjects with functional (and possibly sensitized) nociceptors in the affected skin as revealed by testing with topical capsaicin. Screening for cutaneous nociceptor function may help distinguish candidates for topical therapy for neuropathic pain.

Original languageEnglish (US)
Pages (from-to)1815-1823
Number of pages9
JournalPain
Volume153
Issue number9
DOIs
StatePublished - Sep 2012

Keywords

  • Capsaicin
  • Clinical trial
  • Diabetic neuropathy
  • PDN
  • Pain
  • Topical clonidine

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy'. Together they form a unique fingerprint.

Cite this